semaglutide gp 1.0 mg (Ozempic) Reduced Kidney Events 24% in FLOW Trial Government ploughs £40m into semaglutide
Description
The other authors declare no conflicts of interest relevant to this paper
Inputs can be entered incorrectly

Others experience side effects that make treatment difficult to maintain

The Wegovy pill is a once-daily oral form of semaglutide, the same active ingredient as the Wegovy injection

However, in July 2024, a Harvard study showed that Ozempic users had a 7 times higher risk of sudden vision issues, including blurred vision and blindness, due to NAION

During the trial, blood samples from six subjects for rosuvastatin pharmacokinetic analysis were accidentally thawed during shipment, making the assessment of rosuvastatin pharmacokinetic endpoints impossible for these subjects
